DHEA Hormone Optimization: What It Does (2026)

DHEA is one of the most abundant steroid hormones in the human body at age 25 — and one of the most ignored by the time most adults start asking why they feel off. This guide covers what DHEA does, how it fits into dhea hormone optimization protocols, and exactly who benefits from testing and treatment.

TL;DR: DHEA (dehydroepiandrosterone) is a precursor hormone produced by the adrenal glands that converts into estrogen and testosterone in peripheral tissues. Levels peak around age 25 and decline roughly 2% per year after that. By age 50, most adults have DHEA-S levels 50–80% lower than their peak. Low DHEA is associated with fatigue, reduced libido, poor stress tolerance, and accelerated skin aging. Testing is a simple blood draw (DHEA-S, not free DHEA). Supplementation is appropriate for confirmed deficiency — not as a general wellness booster.

Why DHEA Matters More Than Most Hormone Panels Show

Standard lab panels ordered in a routine physical almost never include DHEA-S. That omission matters because DHEA sits upstream of both estrogen and testosterone. When DHEA is low, the downstream hormones are harder to optimize — even with direct replacement of estrogen or testosterone. Clinicians at GoodLife Health include DHEA-S in their baseline hormone panels for this reason.

The age-related decline is not subtle. The New England Journal of Medicine and multiple longitudinal studies have documented the DHEA drop across adulthood; a 2026 review of adrenal aging data puts average DHEA-S at roughly 400–500 mcg/dL at age 25 and below 150 mcg/dL by age 60 in women, with a similar slope in men. That is not a rounding error — it is a 65–70% reduction over 35 years.

What You'll Need Before Starting

• A DHEA-S lab result (serum, not saliva — more reproducible)
• A full hormone panel: total testosterone, free testosterone, estradiol, progesterone (women), SHBG, cortisol, and TSH at minimum
• A clinician who reads the labs in context — not a reference range that flags everything "normal" as long as it is above the lab's floor
• A baseline symptom inventory: libido, energy, sleep quality, mood stability, skin quality, and recovery from exercise
• For women: cycle status (premenopausal, perimenopausal, postmenopausal) because it changes target ranges
• For men: PSA if over 40, because DHEA converts to testosterone, which affects prostate tissue

The Steps: Evaluating and Acting on DHEA

Step 1 — Test DHEA-S, Not Free DHEA

DHEA circulates mostly as DHEA-sulfate (DHEA-S). The sulfated form has a longer half-life (8–12 hours vs. 30 minutes for free DHEA), making it far more stable across a single blood draw. Saliva tests for DHEA vary significantly by collection time and hydration status. Order DHEA-S, serum, drawn in the morning.

Expected outcome: a number in mcg/dL you can track over time. Low is generally below 100 mcg/dL for women and below 150 mcg/dL for men, though optimal ranges for symptom resolution typically land between 150–300 mcg/dL for women and 300–500 mcg/dL for men. Your clinician interprets this against your age and symptom picture — not against the lab's blanket reference range.

Common mistake: ordering a "hormone panel" from a direct-to-consumer kit that gives DHEA via saliva and skips DHEA-S entirely. The number will be inconsistent and not comparable to clinical literature.

Step 2 — Map DHEA to the Full Hormone Picture

DHEA does not act in isolation. Before supplementing, a clinician needs to see:

• Cortisol — chronic high cortisol (from HPA axis dysregulation) actively suppresses DHEA production. Supplementing DHEA without addressing cortisol is patching a leak without fixing the pipe.
• SHBG — sex hormone-binding globulin determines how much free testosterone is available after DHEA converts. High SHBG means more DHEA conversion produces less bioavailable testosterone.
• Thyroid — subclinical hypothyroidism blunts adrenal function. A TSH above 2.5 with symptoms warrants a full thyroid panel before attributing fatigue to DHEA alone.

This context check is what separates a thoughtful protocol from handing someone a 25 mg capsule because their energy is low.

Step 3 — Determine the Right Dose (It Is Smaller Than You Think)

Over-the-counter DHEA supplements typically come in 25 mg and 50 mg doses. Most clinical protocols for women start at 5–10 mg daily. Men typically start at 25 mg. The reason for the lower female dose: DHEA converts preferentially to androgens in women, and even modest doses can push free testosterone into ranges that cause acne, hair thinning, or clitoral sensitivity changes.

2026 clinical consensus from endocrinology literature supports starting low and re-testing at 6–8 weeks, not assuming the standard OTC dose is therapeutic.

For postmenopausal vaginal atrophy specifically, intravaginal DHEA (prasterone, brand name Intrarosa) is FDA-approved at 6.5 mg nightly and acts locally without significantly raising systemic DHEA-S — an important distinction for women who cannot or prefer not to use systemic hormones.

Common mistake: a patient reads that their DHEA-S is "low" and takes 50 mg daily without retesting for 6 months. By then, testosterone and estradiol may be out of range in the other direction.

Step 4 — Retest at 6–8 Weeks and Adjust

DHEA-S responds relatively quickly to oral supplementation. A retest at 6–8 weeks gives a stable picture of how the dose is landing and whether downstream hormones have shifted. The clinical goal is not to maximize DHEA-S — it is to move it into the range associated with symptom improvement without driving testosterone or estradiol out of therapeutic windows.

If DHEA-S has not moved meaningfully, consider:

• Absorption issues (oral vs. sublingual or topical delivery)
• Continued cortisol suppression
• Compounding pharmacy formulation vs. pharmaceutical-grade supplement quality variance

Expected outcome at a correct dose: improved energy within 4–6 weeks, improved libido within 6–10 weeks, modest skin texture improvement over 3–4 months. Sleep quality often improves as a secondary effect, particularly in men whose low DHEA-S correlates with low testosterone.

Step 5 — Integrate DHEA With the Broader Hormone Protocol

DHEA rarely stands alone in a well-designed hormone optimization protocol. For women in perimenopause, DHEA is frequently prescribed alongside estradiol and progesterone — because estrogen and progesterone replacement does not restore DHEA, and the androgens from DHEA conversion support energy, mood, and libido in ways estrogen alone does not. The hormone optimization guide for women in perimenopause covers where DHEA sits in that broader framework.

For men, DHEA supplementation is sometimes used as a first step before committing to testosterone replacement therapy, particularly in men whose total testosterone is low-normal (350–450 ng/dL) and whose DHEA-S is simultaneously low. If DHEA restores downstream testosterone to symptomatic relief, full TRT may not be necessary.

Common mistake: treating DHEA as the last addition to a protocol rather than reviewing it at the start — when it could be reshaping the entire downstream picture.

Step 6 — Know When DHEA Is Not the Answer

DHEA is not indicated for:

• Normal DHEA-S levels with vague fatigue (chase the correct diagnosis, not a supplement)
• Hormone-sensitive cancers — DHEA converts to estrogen and testosterone; anyone with a history of breast, ovarian, uterine, or prostate cancer needs oncology clearance before use
• Adolescents or young adults with normal adrenal function
• Polycystic ovarian syndrome (PCOS) — androgens are typically already elevated; DHEA will worsen the imbalance

Troubleshooting

DHEA-S is low but symptoms are not improving at 8 weeks. Check cortisol. High cortisol blunts DHEA action even when levels are repleted. A 4-point cortisol test (morning, noon, afternoon, night) identifies HPA axis dysregulation that undermines the protocol.

Acne or oily skin developing within 4 weeks (women). Dose is likely too high for androgen conversion rate. Drop to 5 mg and retest in 6 weeks. Some women do better on intravaginal prasterone if the indication is vaginal atrophy specifically.

Testosterone rising into high-normal but DHEA-S is still low. This pattern suggests DHEA is converting preferentially to testosterone. The dose may be appropriate; do not raise it. Reassess whether direct testosterone therapy is also in the protocol — additive effects may push free testosterone too high.

No movement in DHEA-S after 8 weeks of oral supplementation. Oral delivery is subject to first-pass hepatic metabolism. Sublingual or topical DHEA formulations have higher bioavailability. Discuss a compounded transdermal option with your clinician.

DHEA-S is high but patient still feels fatigued. DHEA is not the problem. Order a full thyroid panel (Free T3, Free T4, reverse T3, TPO antibodies) and ferritin. Iron deficiency and subclinical hypothyroidism are the two most common mimics of DHEA deficiency symptoms.

Patient is taking oral DHEA but estradiol is not moving (postmenopausal women). Conversion of DHEA to estrogen is tissue-dependent and declines with age. Peripheral aromatization is less efficient in postmenopausal women. This patient likely needs direct estradiol therapy, not higher DHEA.

Tools and Resources

• DHEA-S serum test (ordered through your clinician or an independent lab panel)
• Full hormone panel: testosterone, free testosterone, estradiol, progesterone, SHBG, TSH, cortisol
• For women navigating perimenopause: perimenopause symptoms and hormone testing guide
• For men with confirmed low testosterone: low testosterone symptoms in men — what labs actually show
• To understand your full lab picture: how to read your hormone lab results
• GoodLife Health memberships (from $179/month) include clinician-reviewed lab ordering, interpretation, and protocol design — a structure where DHEA is assessed alongside every other relevant marker, not ordered in isolation

What to Do Next

If you have not had a DHEA-S drawn, that is the first move — not supplementing. If you have a number and are not sure where it falls relative to your full hormone picture, the hormone optimization guide for energy and mood explains how clinicians interpret interconnected markers together rather than one at a time.

For adults who want a clinician to review labs, build a protocol, and monitor outcomes — rather than guessing at doses from a supplement label — GoodLife Health memberships start at $179/month and include ongoing lab oversight.

FAQ

What is DHEA and what does it do in the body? DHEA (dehydroepiandrosterone) is a steroid hormone made by the adrenal glands that serves as a precursor to both estrogen and testosterone. It peaks around age 25 and declines approximately 2% per year, meaning most 50-year-olds have DHEA-S levels 50–60% below their peak.

Who actually needs DHEA supplementation? Adults with confirmed low DHEA-S on a serum blood test who have symptoms — fatigue, reduced libido, poor stress recovery, or accelerated skin aging — are the appropriate candidates. Supplementing with normal DHEA-S levels provides no benefit and may push downstream hormones out of range.

Is DHEA safe for women? At the correct dose (typically 5–10 mg daily for women), DHEA is generally well-tolerated. Higher doses cause androgenic side effects: acne, oily skin, and hair thinning. Women with hormone-sensitive cancer history should not use DHEA without oncology clearance.

How long does it take for DHEA to work? Energy and mood improvements typically appear within 4–6 weeks at a therapeutic dose. Libido improvements take 6–10 weeks. Skin texture changes develop over 3–4 months. Retesting DHEA-S at 6–8 weeks confirms the dose is landing correctly.

What is the difference between DHEA and DHEA-S on a lab test? DHEA-S is the sulfated form with an 8–12 hour half-life, making it stable for a single morning blood draw. Free DHEA has a 30-minute half-life and fluctuates significantly. DHEA-S is the clinically relevant measurement for monitoring supplementation.

Can DHEA replace testosterone therapy in men? In some men with low-normal testosterone (350–450 ng/dL) and simultaneously low DHEA-S, supplementing DHEA raises downstream testosterone enough to resolve symptoms without direct TRT. For men with total testosterone below 300 ng/dL, DHEA alone is unlikely to be sufficient.

Does DHEA interact with other hormone treatments? Yes. DHEA adds to the androgenic and estrogenic load of any existing hormone replacement protocol. A clinician needs to see the full picture — including estradiol, testosterone, and SHBG — before adding DHEA to an existing regimen.

What is a normal DHEA-S level in 2026 clinical practice? Optimal ranges in 2026 clinical protocols typically target 150–300 mcg/dL for women and 300–500 mcg/dL for men, interpreted in context of age and symptoms. Lab reference ranges are wider and less useful for treatment decisions.

One Last Thing

DHEA is one of the few hormones where the pharmaceutical-grade supplement market and the clinical prescription world overlap — meaning you can buy it at a pharmacy without a prescription in the US, which creates the illusion that it does not require clinical oversight. It does. The dose matters, the downstream conversion matters, and the interaction with cortisol, SHBG, and thyroid function matters. The number on the bottle is not a protocol.

Related Reading

• Bioidentical Hormone Therapy for Women 2026
• Bioidentical vs Synthetic Hormones: 2026 Guide
• Best Direct Primary Care Membership Plans 2026
• Concierge Medicine Membership for Preventive Care 2026

References

1. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. 2015. doi.org/10.1210/jc.2015-2236
2. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. 2018. doi.org/10.1210/jc.2018-00229